Your GP can: Assess your current weight, BMI, and metabolic health to determine clinical need Review existing treatment options that are currently licensed and available in the UK, which may include orlistat, naltrexone/bupropion (Mysimba), semaglutide 2.4 mg (Wegovy approved by the MHRA for weight management and subject to NICE guidance on eligibility, service setting, and treatment duration), and tirzepatide (Mounjaro check current MHRA and NICE status at the time of reading, as licensing and commissioning arrangements may have been updated) Discuss eligibility for NHS Tier 3 or Tier 4 specialist weight management services , in line with NICE guidance on obesity management, where pharmacotherapy is used as an adjunct to structured lifestyle intervention Signpost you to relevant clinical trials via the Be Part of Research portal or ClinicalTrials.gov if you wish to explore participation in retatrutide research It is important to approach information about investigational medicines with appropriate caution

NEUROLOGICAL SUPPORT Preliminary research suggests that this peptide has brain-supportive benefits, promoting the integrity of the nerve tissue, even in strenuous circumstances where there is excessive stress on the brain
This translational pipeline highlights KDS2010 as a first-in-class therapy, bridging preclinical insights to clinical applications and establishing astrocyte-targeted interventions as a novel paradigm in PTSD treatment
In clinical studies, Glutathione is well-tolerated at typical doses
Vitamin B12 shots may help reduce the risk of serious conditions such as heart disease and stroke as well as cognitive issues, infertility, and neural tube defects (when mothers have B12 deficiency)